Pursuant to Reg 29 and other applicable provisions of SEBI LODR Reg, 2015 this is to inform you that a meeting of the Board of Directors of the Company held on 18th June 2026 has considered and transacted the attached businesses for the change of management related.1. Appointment of the Internal Auditor, M/s. Dharti Shah & Co. and Appointment of Mr. Hemant Amrish Parikh (DIN: 00027820) as an additional non-executive non-independent director.
Announcement under Regulation 30 (LODR)-Change in Management
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Board Meeting Outcome for Outcome Of Board Meeting To Be Held At 18Th June, 2026
- Vivanza Biosciences Ltd. Press Release Jun 15 2026
- Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Pursuant To Regulations 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vivanza Biosciences Ltd. Press Release Apr 30 2026
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Later from Vivanza Biosciences
- Closure of Trading Window
- Vivanza Biosciences Ltd. Press Release Jun 26 2026
- Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
- Vivanza Biosciences Ltd. Press Release Jun 29 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences